These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3856070)

  • 1. Antitumor activity of the DNA fraction from Mycobacterium bovis BCG. II. Effects on various syngeneic mouse tumors.
    Shimada S; Yano O; Inoue H; Kuramoto E; Fukuda T; Yamamoto H; Kataoka T; Tokunaga T
    J Natl Cancer Inst; 1985 Mar; 74(3):681-8. PubMed ID: 3856070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity.
    Tokunaga T; Yamamoto H; Shimada S; Abe H; Fukuda T; Fujisawa Y; Furutani Y; Yano O; Kataoka T; Sudo T
    J Natl Cancer Inst; 1984 Apr; 72(4):955-62. PubMed ID: 6200641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
    Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
    Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors.
    Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K
    Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effects of recombinant BCG and interleukin-12 DNA vaccines on xenografted murine bladder cancer.
    Yu DS; Lee CF; Hsieh DS; Chang SY
    Urology; 2004 Mar; 63(3):596-601. PubMed ID: 15028475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis.
    Suga T; Shiio T; Maeda YY; Chihara G
    Cancer Res; 1984 Nov; 44(11):5132-7. PubMed ID: 6488173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic antitumor effects of BCG and monoclonal antibodies capable of inducing antibody-dependent cell-mediated cytotoxicity.
    Komuta K; Kawase I; Ogura T; Masuno T; Yokota S; Hosoe S; Ikeda T; Shirasaka T; Kishimoto S
    Jpn J Cancer Res; 1987 Feb; 78(2):185-92. PubMed ID: 3104261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer.
    Utsugi T; Shibata J; Sugimoto Y; Aoyagi K; Wierzba K; Kobunai T; Terada T; Oh-hara T; Tsuruo T; Yamada Y
    Cancer Res; 1996 Jun; 56(12):2809-14. PubMed ID: 8665518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
    Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
    Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineoplastic effects of egg-white lysozyme in mice bearing solid metastasizing tumors.
    Sava G; Perissin L; Zorzet S; Callerio C
    Anticancer Res; 1986; 6(2):183-6. PubMed ID: 3707053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo antitumor activity of various forms of delayed-type hypersensitivity in mice.
    Lagrange PH; Thickstun PM
    J Natl Cancer Inst; 1979 Feb; 62(2):429-36. PubMed ID: 283275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unanticipated effect of BCG in mice treated by radiotherapy.
    Serrou B; Dubois JB
    Dev Biol Stand; 1977 Apr 13-15; 38():369-72. PubMed ID: 344099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of sensitization and delayed hypersensitivity reaction on tumor growth in mice].
    Polushkin BV; Gordienko SM
    Vopr Onkol; 1980; 26(7):51-6. PubMed ID: 7405105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo.
    O'Dwyer PJ; Moyer JD; Suffness M; Harrison SD; Cysyk R; Hamilton TC; Plowman J
    Cancer Res; 1994 Feb; 54(3):724-9. PubMed ID: 8306334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors.
    Li C; Price JE; Milas L; Hunter NR; Ke S; Yu DF; Charnsangavej C; Wallace S
    Clin Cancer Res; 1999 Apr; 5(4):891-7. PubMed ID: 10213226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of protein-bound polysaccharide from Cordyceps ophioglossoides in mice.
    Ohmori T; Tamura K; Tsuru S; Nomoto K
    Jpn J Cancer Res; 1986 Dec; 77(12):1256-63. PubMed ID: 3102430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic cell therapy for a murine mammary carcinoma.
    Morecki S; Yacovlev E; Diab A; Slavin S
    Cancer Res; 1998 Sep; 58(17):3891-5. PubMed ID: 9731499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumors.
    Guilbaud N; Kraus-Berthier L; Meyer-Losic F; Malivet V; Chacun C; Jan M; Tillequin F; Michel S; Koch M; Pfeiffer B; Atassi G; Hickman J; Pierré A
    Clin Cancer Res; 2001 Aug; 7(8):2573-80. PubMed ID: 11489841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4'-O-tetrahydropyranyladriamycin as a potential new antitumor agent.
    Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
    Cancer Res; 1982 Apr; 42(4):1462-7. PubMed ID: 7060020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy of murine tumor with syngeneic antitumor serum plus BCG.
    Yamazaki M; Saito M; Abe S; Mizuno D
    Jpn J Exp Med; 1983 Feb; 53(1):27-32. PubMed ID: 6876475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.